Ansh Enterprises

Feruno 500 mg/5 ml Injection belongs to the class of \'haematinics,\' primarily used to treat iron deficiency anaemia. It is useful to treat anaemia in patients with long-term kidney diseases. Iron deficiency anaemia is a condition in which the body does not have enough red blood cells to carry adequate oxygen required to various body tissues due to insufficient iron. Feruno 500 mg/5 ml Injection contains Iron (III) isomaltoside 1000/Ferric derisomaltose, an iron replacement product required by the red blood cells to carry oxygen to other body cells and tissues. Iron isomaltoside is a compound that releases iron, which binds to transferrin, a transport protein. The transferrin takes the iron to erythroid precursor cells (cells that develop into mature red blood cells) for incorporation into the haemoglobin molecule.

Feruno 1000mg Injection contains an active ingredient called Iron (III) Isomaltoside. It belongs to the medication class known as anti-anemic medicines. It is used as an iron replacement medicine to treat iron deficiency anemia in adults who are intolerant to oral iron or have not responded well to oral iron preparations. Additionally, this medication treats this condition in individuals with chronic kidney disease who are on dialysis and cannot take oral iron supplementation. Due to limited data on safety and efficacy, Feruno 1000mg Injection is not recommended for use in individuals under the age of 18, including children and adolescents. Feruno 1000mg Injection should not be consumed if you are allergic to Iron (III) Isomaltoside or any of its ingredients in the medication. Do not take this medicine if the anemia was not caused by iron deficiency (such as "hemolytic" anemia), if you have iron overload or impaired iron utilization, or if you have a history of severe allergic reactions to other injectable iron preparations and active liver diseas